Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,023+, returning 13,702.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 13,702.4% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 5,794.84% |
DeFi Development (DFDV) | 2,561.61% |
Zepp Health (ZEPP) | 2,256.54% |
WW International, Inc Common Stock (WW) | 1,948.09% |
Abits (ABTS) | 1,211.91% |
Oncology Institute (TOI) | 1,177.78% |
FiEE (FIEE) | 1,166.06% |
Abivax SA American Depositary Shares (ABVX) | 1,151.52% |
Nanobiotix (NBTX) | 861.74% |
Global Interactive Technologies (GITS) | 775.52% |
Above Food Ingredients Inc Common Stock (ABVE) | 765.45% |
Lizhi (SOGP) | 749.15% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 739.96% |
TMC the metals (TMC) | 722.81% |
Nova Lifestyle I (NVFY) | 707.87% |
Airnet Technology (ANTE) | 627.88% |
Dominari (DOMH) | 602.08% |
mF International Limited Ordinary Shares (MFI) | 560.94% |
Better Home & Finance (BETR) | 551.45% |
Oklo (OKLO) | 550.64% |
ThredUp (TDUP) | 536.11% |
Mobilicom Limited Warrants (MOBBW) | 530.98% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 528.93% |
